Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Dr Manuele Michelessi
Advertisement
Articles by Dr Manuele Michelessi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Beyond anti-VEGF: The next wave in retinal therapy
2
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
3
Trehalose-hyaluronate combination aids tear film after eyelid surgery
4
ZEISS reports early implantations of AT LUCIA Toric 721P IOL in Europe
5